ATE159186T1 - Verfahren zur erhöhung der stabilität von nanokapseln während deren lagerung - Google Patents

Verfahren zur erhöhung der stabilität von nanokapseln während deren lagerung

Info

Publication number
ATE159186T1
ATE159186T1 AT94200884T AT94200884T ATE159186T1 AT E159186 T1 ATE159186 T1 AT E159186T1 AT 94200884 T AT94200884 T AT 94200884T AT 94200884 T AT94200884 T AT 94200884T AT E159186 T1 ATE159186 T1 AT E159186T1
Authority
AT
Austria
Prior art keywords
nanocapsules
stability
storage
increase
temperature
Prior art date
Application number
AT94200884T
Other languages
English (en)
Inventor
Valdivia Francisco Javie Galan
Dachs Anna Coll
Perdiguer Nuria Carreras
Original Assignee
Cusi Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cusi Lab filed Critical Cusi Lab
Application granted granted Critical
Publication of ATE159186T1 publication Critical patent/ATE159186T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B01J13/203—Exchange of core-forming material by diffusion through the capsule wall
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/701—Integrated with dissimilar structures on a common substrate
    • Y10S977/715—On an organic substrate
    • Y10S977/717—Lipid substrate
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
AT94200884T 1993-04-20 1994-03-30 Verfahren zur erhöhung der stabilität von nanokapseln während deren lagerung ATE159186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09300827A ES2070076B1 (es) 1993-04-20 1993-04-20 Metodo para aumentar la estabilidad de las nanocapsulas durante su almacenamiento.

Publications (1)

Publication Number Publication Date
ATE159186T1 true ATE159186T1 (de) 1997-11-15

Family

ID=8281529

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94200884T ATE159186T1 (de) 1993-04-20 1994-03-30 Verfahren zur erhöhung der stabilität von nanokapseln während deren lagerung

Country Status (9)

Country Link
US (1) US5885491A (de)
EP (1) EP0621073B1 (de)
JP (1) JPH0815550B2 (de)
AT (1) ATE159186T1 (de)
DE (1) DE69406178T2 (de)
DK (1) DK0621073T3 (de)
ES (1) ES2070076B1 (de)
GR (1) GR3025888T3 (de)
HK (1) HK1011943A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008305A1 (de) * 2000-02-23 2001-09-06 Henkel Kgaa Mittel zur Reinigung und Pflege von Haut und/oder Haaren
FR2805761B1 (fr) 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
US20060286064A1 (en) * 2000-08-30 2006-12-21 Medivas, Llc Therapeutic polymers and methods
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
EP1429749A2 (de) * 2001-09-26 2004-06-23 Baxter International Inc. Herstellung von nanopartikeln im submikrometerbereich durch dispersion und entzug des lösungsmittels oder der flüssigen phase
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US20060222694A1 (en) * 2003-06-27 2006-10-05 Oh Choon K Stabilized topotecan liposomal composition and methods
CA2623198C (en) 2005-09-22 2014-08-05 Medivas, Llc Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
CA2623239C (en) * 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
WO2007067744A2 (en) * 2005-12-07 2007-06-14 Medivas, Llc Method for assembling a polymer-biologic delivery composition
CA2649672C (en) * 2006-05-02 2015-07-07 Medivas, Llc Delivery of ophthalmologic agents to the exterior or interior of the eye
EP2021141A4 (de) * 2006-05-09 2013-07-03 Medivas Llc Biologisch abbaubare wasserlösliche polymere
EP2068937A2 (de) * 2006-09-05 2009-06-17 Medivas, LLC Polymer-stabilisierte liposomale zusammensetzungen und anwendungsverfahren dafür
EP2178944A1 (de) * 2007-07-24 2010-04-28 Medivas, LLC Biologisch abbaubare polymere genübertragungszusammensetzungen und anwendungsverfahren dafür
JP2012500207A (ja) * 2008-08-13 2012-01-05 メディバス エルエルシー Ａａｂｂ−ポリ（デプシペプチド）生分解性ポリマー及び使用方法
JP2011241147A (ja) * 2008-08-29 2011-12-01 Nano Egg:Kk インドメタシン含有ナノカプセルおよびその製造方法
US8666685B2 (en) 2011-04-19 2014-03-04 Schneider Electronic IT Corporation System of intelligent sensors in an electrical panelboard
US8660810B2 (en) 2011-04-19 2014-02-25 Schneider Electric It Corporation System and method to calculate RMS current and true power in a multidrop sensor network
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
US9963549B2 (en) 2011-06-23 2018-05-08 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP3233067B1 (de) 2014-12-18 2019-11-06 DSM IP Assets B.V. Arzneimittelabgabesystem zur abgabe von säureempfindlichen arzneimitteln
EP3427724A4 (de) * 2016-03-10 2019-11-13 Sumitomo Dainippon Pharma Co., Ltd. Zusammensetzung mit feinen partikeln und verfahren zur herstellung davon

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
JPS57147430A (en) * 1981-03-06 1982-09-11 Kureha Chem Ind Co Ltd Preparation of microcapsule
FR2515960A1 (fr) * 1981-11-06 1983-05-13 Alkhouri Fallouh Nazir Nanocapsules ou nanoparticules biodegradables contenant une substance biologiquement active, leur preparation et leur application
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3678308D1 (de) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
US5204112A (en) * 1986-06-16 1993-04-20 The Liposome Company, Inc. Induction of asymmetry in vesicles
FR2608942B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanocapsules
US5093198A (en) * 1987-06-19 1992-03-03 Temple University Adjuvant-enhanced sustained release composition and method for making
JP3226300B2 (ja) * 1990-07-18 2001-11-05 エーザイ株式会社 プロナノスフィア及びその製造方法
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
US5250236A (en) * 1991-08-05 1993-10-05 Gasco Maria R Method for producing solid lipid microspheres having a narrow size distribution
FR2692168B1 (fr) * 1992-06-16 1995-03-24 Centre Nat Rech Scient Préparation et utilisation de nouveaux systèmes colloïdaux dispersibles à base de cyclodextrine, sous forme de nanosphères.
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Also Published As

Publication number Publication date
US5885491A (en) 1999-03-23
DK0621073T3 (da) 1998-06-02
HK1011943A1 (en) 1999-07-23
EP0621073B1 (de) 1997-10-15
ES2070076B1 (es) 1996-04-16
DE69406178D1 (de) 1997-11-20
JPH0815550B2 (ja) 1996-02-21
EP0621073A1 (de) 1994-10-26
DE69406178T2 (de) 1998-06-04
ES2070076A1 (es) 1995-05-16
GR3025888T3 (en) 1998-04-30
JPH06343854A (ja) 1994-12-20

Similar Documents

Publication Publication Date Title
ATE159186T1 (de) Verfahren zur erhöhung der stabilität von nanokapseln während deren lagerung
ATE84681T1 (de) Karrageenan enthaltendes waessriges gel.
ATE201333T1 (de) Verfahren zur herstellung von wasseradsorptionsmaterial und dessen verwendung in hygieneartikeln und zur bodenverbesserung
ATE36447T1 (de) Bindung von fluechtigen stoffen auf einem amorphen substrat und die so erhaltenen produkte.
ATE2113T1 (de) Verfahren zur herstellung von festen arzneimitteln mit troepfchenfoermig aufgebrachten wirkstoffen.
DE69319758D1 (de) Verfahren zur Herstellung von Futterpellets
DE69033874T2 (de) Verfahren zur Herstellung von arzneimittelenthaltenden gefriergetrockneten Formulierungen
Fox et al. Abiotic production of primitive protein and formed microparticles
DE68927669D1 (de) Verfahren zur herstellung von in lösungsmitteln verdünnbaren mikroträgern
PT87658A (pt) Verfahren zur herstellung einer loesung hoher spezifischer volumenaktivitaet von einem protein mit gewebe-plasminogenaktivator (t-pa)-aktivitaet loesung enthaltend protein mit t-pa-aktivitaet und verwendung der loesung in der human- und veterinaermedizin
ATE84710T1 (de) Verfahren zur herstellung von kolloidalen dispergierbaren proteinsystemen, wie nanopartikeln.
DE3888943D1 (de) Verfahren zur Verkapselung.
DE59206398D1 (de) Verfahren zur Herstellung von 1-Carbamoyl-pyrazolen
IT7825713A0 (it) Derivati d'acido ciclopropancarbossilico, processo per la loro produzione e loro impiego come prodotti per laproduzione d'insetticidi.
CA2069256A1 (en) Method of preparing .alpha.-l-aspartyl-l-phenylalanine methyl ester
AT315159B (de) Verfahren zur gemeinsamen Spaltung von dl-Kampfer-10-sulfonsäure und α-dl-4-Dimethylamino-1,2-diphenyl-3-methyl-2-butanol in ihre entsprechenden optisch aktiven d- und 1-Isomeren
DE69617452D1 (de) Verfahren und gerät zur behandlung von flüssigeiprodukten
ATE163541T1 (de) Herstellungsverfahren von mit biologischen strukturen, biopolymeren und/oder oligomeren beladenen vesikeln
ATE156660T1 (de) Verfahren zur erleichterung der ernte von nahrungserträgen
Vol'kenshteĭn et al. Electronic-conformational interactions of molecular-biological systems. I. Quantum-chemical aspect of the theory of electronic-conformational interaction
DE59802825D1 (de) Verfahren zur Herstellung von 4-Nitro-2-sulfo-benzoesäure
ATE193897T1 (de) Ein verfahren zur herstellung eines nicht- faserigen porösen stoffes
ATE159516T1 (de) Verfahren zur herstellung von isocyansäure aus cyanursäure
PT65900A (de) 5-alkylureido-1,3,4-thiadiazol-2-yl-sulfonyl-essigsaeure-derivate,verfahren zur herstellung diesel verbindungen sowie diese enthaltende herbizide mittel
RU93048540A (ru) Водная дисперсия зеина, способ получения, твердый препарат с регулируемой проницаемостью по основному продукту

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee